I have prepared here a list of top 20 option (CDYOA) holders comparing the holding with that published on April 1st as a consequence of the March 2021 capital raising.
Some of the levels held in April would not seem to be explained by the potential 1 option for every 5 shares then held. They might be explained by the supplementary offering of new shares where 1 option was provided for every 2 new shares purchased in that supplementary offer.
There is one substantial seller of options it seems. This appears to take place from a holding level that does not seem immediately obvious from the 1 for 5 previously held shares, nor from the current top 20 share holding list. The options may have come from the supplementary offer with the corresponding new shares, of abut 5 million, now having been sold down.
There have been some quite substantial acquisitions of CDYOA since April, including 7-figure amounts. The total options traded has been 8,827,258 of which the first trade was 6th April.
Food for reflective cogitations.
poorinvestor
- Forums
- ASX - By Stock
- AN1
- Ann: Appendix 4E and FY21 Financial Report
Ann: Appendix 4E and FY21 Financial Report, page-42
-
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $4.704K | 588K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 697002 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 340000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 697002 | 0.008 |
3 | 1953225 | 0.007 |
4 | 1006527 | 0.006 |
1 | 300000 | 0.005 |
2 | 525000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 340000 | 1 |
0.010 | 100000 | 1 |
0.011 | 100000 | 1 |
0.012 | 300000 | 2 |
0.013 | 750000 | 1 |
Last trade - 15.07pm 03/07/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online